Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Recent Advances in Research for Tuberculosis

결핵 연구의 최근 성과들

  • Yim, Jae Joon (Division of Pulmonary and Critical Care Medicine, Dept. of Internal Medicine and Lung Institute of Medicine Research Center, Seoul National University College of Medicine)
  • 임재준 (서울대학교 의과대학 내과학교실 및 폐연구소)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Jimenez-Corona ME, Garcia-Garcia L, DeRiemer K, Ferreyra-Reyes L, Bobadilla-det-Valle M, Cano-Arellano B, et al. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax 2006;61:348-53 https://doi.org/10.1136/thx.2005.049452
  2. Uplekar MW, Rangan S, Weiss MG, Ogden J, Borgdorff MW, Hudelson P. Attention to gender issues in tuberculosis control. Int J Tuberc Lung Dis 2001;5:220-4
  3. Balasubramanian R, Garg R, Santha T, Gopi PG, Suhramani R, Chandrasekaran V, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis 2004;8:323-32
  4. Tekkel M, Rahu M, Loit HM, Baburin A. Risk factors for pulmonary tuberculosis in Estonia. Int J Tuberc Lung Dis 2002;6:837-94
  5. Curtis AB, Ridzon R, Novick LF, Driscoll J, Blair D, Oxtoby M, et al. Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis 2000;4:308-13
  6. Garcia-Garcia M, Palacios-Martinez M, Ponce-de-Leon A, Jimenez-Corona ME, Jimenez-Corona A, Balandrano- Campos S, et al. The role of core groups in transmitting Mycobacterium tuberculosis in a high prevalence community in Southern Mexico. Int J Tuherc Lung Dis 20004:12-7
  7. Bates I, Fenton C, Gruber J, Lalloo D, Lara AM, Squire SB, et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease, Part II: Determinants operating at environmental and institutional level. Lancet Infect Dis 2004;4:368-75 https://doi.org/10.1016/S1473-3099(04)01047-3
  8. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004;27:1584-90 https://doi.org/10.2337/diacare.27.7.1584
  9. Thulstrup AM, Molle I, Svendsen N, Sorensen HT, Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study. Epidemiol Infect 2000;124: 221-5 https://doi.org/10.1017/S0950268899003593
  10. Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD, Bosman M, et al. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis 2007;11:195-201
  11. Godfrey-Faussett P, Sonnenberg P, Sheater SC, Bruce MC, Mee C, Morris L, et al. Tuberculosis control and molecular epidemiology in a South African goldmining community. Lancet 2000;366:1006-71
  12. Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME, Jimenez-Corona A, Palacios-Martinez M, Balandrano- Campos S, et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch Intern Med 2000;160:630-6 https://doi.org/10.1001/archinte.160.5.630
  13. Kruuner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001;39:3339-45 https://doi.org/10.1128/JCM.39.9.3339-3345.2001
  14. Teixeira L, Perkins MD, Johnson JL, Keller R, Palaci M, do Valle Dettoni V, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2001;5:321-8
  15. van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H, Borgdorff MW, Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands, J Infect Dis 2000;182:1788-90 https://doi.org/10.1086/317598
  16. Pym AS, Saint-Joanis B, Cole ST. Effect of katG mutations on the virulence of Mycobacterium tuberculosls and the implication for transmission in humans. Infect Immun 2002;70:4900-60
  17. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness, Lancet 2006;367:1173-80 https://doi.org/10.1016/S0140-6736(06)68507-3
  18. Rodrigues LC, Diwan VK, Wheeler JG, Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8 https://doi.org/10.1093/ije/22.6.1154
  19. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Metaanalysis of the published literature. JAMA 1994;271:698-702 https://doi.org/10.1001/jama.271.9.698
  20. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, et al. Comparison of two commercial interferongamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006;28:24-30 https://doi.org/10.1183/09031936.06.00016906
  21. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47 https://doi.org/10.1164/ajrccm.161.supplement_3.ats600
  22. Kang YA, Lee HW, Ycon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61 https://doi.org/10.1001/jama.293.22.2756
  23. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:824-8 https://doi.org/10.1164/ajrccm.163.4.2009100
  24. Sichletidis L, Settas L, Spyratos D, Chloros D, Patakas D. Tuberculosis in patients receiv'ing anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 2006;10:1127-32
  25. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Sehwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpba-neutralizing agent. N engl J Med 2001;345: 1098-104 https://doi.org/10.1056/NEJMoa011110
  26. Koh WJ, Yu CM, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients With AFB smear-positive sputum. Int J Tuberc Lung Dis 2006;10:1001-7
  27. Yim JJ, Park YK, Lew WJ, Bai GH, Ban SK, Shim YS. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci 2005;20:957-60 https://doi.org/10.3346/jkms.2005.20.6.957
  28. Jeon R, Koh WJ, Kwon OJ, Suh GY, Ghung MP, Kim H, et al. Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tubere Lung Dis 2005;9:1046-61
  29. Choi CM, Kang CI, Jeung WK, Kim DH, Lee CH, Yim JJ. Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int J Thberc Lung Dis 2007;11:233-6
  30. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner TH, McClatchy JK, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Mcrobiol 1983;18:689-96
  31. DiStasio AJ, Trump DH, The investigation of a tuberculosis outbreak in the closed environment of a U.S, Navy ship, 1987. Mil Med 1900;155:347-61
  32. Houk VN, Baker JH, Sorensen K, Kent DC, The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968;16:26-36 https://doi.org/10.1080/00039896.1968.10665011
  33. Moore DA, Evans CA, Gilman RH, Caviedes L. Coronel J, Vivar A, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;365:1539-50
  34. Joh JS, Lee CH, Lee JE, Park YK, Dai GH, Kim EC, et al. The interval between initiation of antituberculosis treatment in patients with culturepositive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci 2007;22:26-9 https://doi.org/10.3346/jkms.2007.22.1.26
  35. Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006;174:331-8 https://doi.org/10.1164/rccm.200603-360OC
  36. Mukherjee JS, Rich ML. Socci AR, Joseph JK, Viru FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474-81 https://doi.org/10.1016/S0140-6736(04)15496-2
  37. Yoon YS, Lee HJ, Yoon HI, Yoo CG, Kim YW, Han SK, et al. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia. Int J Tuberc Lung Dis 2005;9:1215-9
  38. Pletz MW, De Roux A, Roth A, Neumann KH, Mauch H, Lode H. Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study. Antimicrob Agents Chemother 2004;48:780-2 https://doi.org/10.1128/AAC.48.3.780-782.2004
  39. Kim HJ, Kang CH, Kim YT, Sung SW, Kim JH, Lee SM, et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis. Eur Respir J 2006;28:576-80 https://doi.org/10.1183/09031936.06.00023006
  40. Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2004;128:523-8 https://doi.org/10.1016/S0022-5223(04)00871-2
  41. Park SK, Lee CM, Heu JP, Song SD. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2002;6:143-9
  42. Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001;121: 448-53 https://doi.org/10.1067/mtc.2001.112339
  43. Chiang CY, Yu MC, Bai KJ, Suo J, Lin TP, Lee YC.Pulmonary resection in the treatment of patients with pulmonary multi drug-resistant tuberculosis in Taiwan. Int J Tuberc Lung Dis 2001;5:272-7
  44. Sung SW, Kang CH, Kim YT, Ban SK, Shim YS, Kim JH. Surgery increased the chance of erne in multi-drug resistant pulmonary tuberculosis. Eur J Cardiothorac Surg 1999;16:187-93 https://doi.org/10.1016/S1010-7940(99)00158-X
  45. van Leuven M, De Groot M, Shean KP, von Oppell UO, Willcox PA. Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis. Ann Thorac Surg 1997;63:1368-72; discuasion 1372-63 https://doi.org/10.1016/S0003-4975(97)80353-0
  46. Kir A, Tahaoglu K, Okur E, Hatipoglu T. Role of surgery in multi-drug-resistant tuberculosis: results of 27 cases, Eur J Cardiothorac Surg 1997;12:531-4 https://doi.org/10.1016/S1010-7940(97)00230-3
  47. Treasure RL, Seaworth BJ. Current role of Surgery in Mycobacterium tuberculosis. Ann Thorac Surg 1995;59:1405-7; discussion 1408-9 https://doi.org/10.1016/0003-4975(95)00145-B
  48. Chan ED, Laurel V, Strand MT, Chan JF, Huynh ML, Goble M, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004;169:1103-9 https://doi.org/10.1164/rccm.200308-1159OC
  49. Tahaoglu K, Torun T, Sevim T, Atac G, Kir A, Karasulu L, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001;346:170-4
  50. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drugresistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80 https://doi.org/10.1016/S0140-6736(06)69573-1
  51. Centers for Disease Control and Prevention (CDC), Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55:301-5
  52. Raviglione M. XDR-TB: entering the post-antibiotic era? Int J Tuberc Lung Dis 2006;10:1185-7